We thank all the members of the A.I. laboratory for their helpful comments and suggestions. We would like to thank Prof. Mark Hipp (Max Planck Institute for Biochemistry) for providing us with the shuttle-GFP vector. This work was supported by grants from the Israeli Science Foundation (ISF #124/14), the Binational Science Foundation (BSF #2013325), FP7 Marie Curie Career Integration Grant (CIG # 333794), and The National Institute for Psychobiology in Israel (NIPI #b133-14/15).

1. Cell Line Preparation
<ol>
	<li>Thaw approximately 1,000,000 mouse neuroblastoma spinal cord cells (NSC-34 cells) that were stored in a liquid nitrogen container. Use a 37 &#176;C water incubator until the cells are fully thawed.</li>
	<li>Add fresh, warm medium (DMEM medium containing 10% fetal bovine serum (FBS), 1% L-glutamine, and 1% pen-strep antibiotics).</li>
	<li>Centrifuge thawed cells (SL16R) at 500 x g for 5 min, forming a cell pellet. Discard the medium and add 1 mL of new medium for the cell resuspensio...

<ol>
	<li>Alberts, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Molecular biology of the cell. , (2002).</li><li>Freitas, N., Cunha, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+and+signals+for+the+nuclear+import+of+proteins.">Mechanisms and signals for the nuclear import of proteins.</a> Curr Genomics. 10, 550-557 (2009).</li><li>Kalderon, D., Roberts, B. L., Richardson, W. D., Smith, A. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+short+amino+acid+sequence+able+to+specify+nuclear+location.">A short amino acid sequence able to specify nuclear location.</a> Cell. 39, 499-509 (1984).</li><li>la Cour, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analysis+and+prediction+of+leucine-rich+nuclear+export+signals.">Analysis and prediction of leucine-rich nuclear export signals.</a> Protein Eng Des Sel. 17, 527-536 (2004).</li><li>Boeynaems, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Drosophila+screen+connects+nuclear+transport+genes+to+DPR+pathology+in+c9ALS/FTD.">Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD.</a> Sci Rep. 6, 20877 (2016).</li><li>Freibaum, B. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=GGGGCC+repeat+expansion+in+C9orf72+compromises+nucleocytoplasmic+transport.">GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport.</a> Nature. 525, 129-133 (2015).</li><li>Jovicic, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Modifiers+of+C9orf72+dipeptide+repeat+toxicity+connect+nucleocytoplasmic+transport+defects+to+FTD/ALS.">Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.</a> Nat Neurosci. 18, 1226-1229 (2015).</li><li>Kwon, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Poly-dipeptides+encoded+by+the+C9orf72+repeats+bind+nucleoli,+impede+RNA+biogenesis,+and+kill+cells.">Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells.</a> Science. 345, 1139-1145 (2014).</li><li>Rossi, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nuclear+accumulation+of+mRNAs+underlies+G4C2-repeat-induced+translational+repression+in+a+cellular+model+of+C9orf72+ALS.">Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS.</a> J Cell Sci. 128, 1787-1799 (2015).</li><li>Shi, K. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Toxic+PRn+poly-dipeptides+encoded+by+the+C9orf72+repeat+expansion+block+nuclear+import+and+export.">Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export.</a> Proc Natl Acad Sci U S A. , (2017).</li><li>Zhang, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+C9orf72+repeat+expansion+disrupts+nucleocytoplasmic+transport.">The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.</a> Nature. 525, 56-61 (2015).</li><li>Zhang, Y. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=C9ORF72+poly(GA)+aggregates+sequester+and+impair+HR23+and+nucleocytoplasmic+transport+proteins.">C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins.</a> Nat Neurosci. 19, 668-677 (2016).</li><li>Cleveland, D. W., Rothstein, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=From+Charcot+to+Lou+Gehrig:+deciphering+selective+motor+neuron+death+in+ALS.">From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.</a> Nat Rev Neurosci. 2, 806-819 (2001).</li><li>DeJesus-Hernandez, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Expanded+GGGGCC+hexanucleotide+repeat+in+noncoding+region+of+C9ORF72+causes+chromosome+9p-linked+FTD+and+ALS.">Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.</a> Neuron. 72, 245-256 (2011).</li><li>Renton, A. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+hexanucleotide+repeat+expansion+in+C9ORF72+is+the+cause+of+chromosome+9p21-linked+ALS-FTD.">A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.</a> Neuron. 72, 257-268 (2011).</li><li>Boeve, B. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+frontotemporal+dementia+and/or+amyotrophic+lateral+sclerosis+associated+with+the+GGGGCC+repeat+expansion+in+C9ORF72.">Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.</a> Brain. 135, 765-783 (2012).</li><li>Haeusler, A. R., Donnelly, C. J., Rothstein, J. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+expanding+biology+of+the+C9orf72+nucleotide+repeat+expansion+in+neurodegenerative+disease.">The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease.</a> Nat Rev Neurosci. 17, 383-395 (2016).</li><li>Woerner, A. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cytoplasmic+protein+aggregates+interfere+with+nucleocytoplasmic+transport+of+protein+and+RNA.">Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA.</a> Science. 351, 173-176 (2016).</li><li>Tao, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nucleolar+stress+and+impaired+stress+granule+formation+contribute+to+C9orf72+RAN+translation-induced+cytotoxicity.">Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity.</a> Hum Mol Genet. 24, 2426-2441 (2015).</li><li>Wen, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antisense+proline-arginine+RAN+dipeptides+linked+to+C9ORF72-ALS/FTD+form+toxic+nuclear+aggregates+that+initiate+in+vitro+and+in+vivo+neuronal+death.">Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death.</a> Neuron. 84, 1213-1225 (2014).</li></ol>

Authors have nothing to disclose.

This protocol demonstrates a highly sensitive and quantitative new assay to evaluate minute changes in nucleocytoplasmic transport. Using this system, it is possible to observe and measure nucleocytoplasmic transport and its dysfunction in real time, not only large defects that result in dramatic changes in protein distribution. This assay not only has a sensitivity advantage, but it also requires little preparation, is inexpensive, and is a very easy and low-engagement assay.
To test the effi...

The nuclear pore complex (NPC) controls the import and export of large molecules into and out of the cell nucleus. In contrast to small molecules, which can enter the nucleus without regulation1, the transport of larger molecules is strongly controlled by the NPC. These large molecules, such as proteins and RNA, associate with transport factors, including importins and exportins, to be imported and exported from the nucleus2. In order to be imported, proteins must contain a small peptide motif, generally called a nuclear localization signal (NLS), which is bound by importins2. These sequences of amino acids act as a tag and are diverse in composition3,4. Proteins can be exported from the nucleus to the cytoplasm due to their association with exportins, which bind a signal sequence, generally called a nuclear export signal (NES)2. Both importins and exportins are able to transport their cargo due to the regulation of the small Ras related nuclear protein GTPase (Ran)2. Ran has been shown to exist in different conformational states depending on whether it is bound to GTP or GDP. When bound to GTP, Ran can bind to importins or exportins. Upon binding to RanGTP, importins release their cargo, while exportins must bind RanGTP to form a complex with their export cargo. The dominant nucleotide binding state of Ran depends on its location in the nucleus (RanGTP) or the cytoplasm (RanGDP).
Recently, a number of studies have shown a connection between impairments in the nucleocytoplasmic pathway and both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)5,6,7,8,9,10,11,12. ALS is a progressive and fatal neurodegenerative disease affecting both upper and lower motor neurons (MNs)13 and resulting in paralysis and ultimately in death, within 2-5 years on average. Most cases of ALS are classified as sporadic (SALS), lacking any apparent genetic linkage, but 10% are inherited in a dominant manner (familial ALS; FALS). Recently, hexanucleotide repeat expansions (HREs) in the chromosome 9 open reading frame 72 (C9orf72) gene were identified14,15 as a genetic cause of ALS and FTD. These mutants account for 30-40% of FALS cases16, and different studies have contended that they cause toxicity by affecting nucleocytoplasmic transport5,6,7,8,9,10,11,12.
These studies have mostly shown the final outcomes and manifestations of HREs on nucleocytoplasmic transport, but they do not demonstrate nucleocytoplasmic disruption in real time. As a result, only severe nucleocytoplasmic transport deficiency has been evaluated11,17,18.
This protocol describes a new and very sensitive assay to evaluate and quantify nucleocytoplasmic transport dysfunction in real time. The rate of import of a NLS-NES-GFP protein (shuttle-GFP) can be quantified in real time using fluorescent microscopy. This is done using an exportin inhibitor, as described previously18, thus allowing the shuttle-GFP only to enter the nucleus. Using florescent microscopy and a software capable of quantifying fluorescent changes in real time, it is possible to quantify gradual changes in the fluorescence intensity of the shuttle-GFP, located in the nucleus. As a result, a Michaelis-Menten-like saturation curve of the fluorescence-to-time axis, representing the amount of nuclear shuttle-GFP at any given time, can be made. By using the initial linear rate of the curves, it is possible to generate a slope, which represents the rate of entry into the nucleus before fluorescence saturation.
To validate the assay, the translated C9orf72 dipeptide repeats, poly(GR) and poly(PR), which have been previously reported to disrupt nucleocytoplasmic transport, were used5,7,8,10,12. Using this assay, a 50% decrease in the nuclear import rate was observed compared to the control. Using this system, minute changes in nucleocytoplasmic transport can be examined. Moreover, the ability of different factors to rescue a nucleocytoplasmic transport defect can be determined.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Mouse Motor Neuron-Like hybrid Cell Line (NSC-34)</td>
			<td>tebu-bio</td>
			<td>CLU140-A</td>
		</tr>
		<tr>
			<td>DMEM 4.5g/L L-glucose</td>
			<td>Biological Industries</td>
			<td>01-055-1A</td>
		</tr>
		<tr>
			<td>FBS European Grade</td>
			<td>Biological Industries</td>
			<td>04-007-1A</td>
		</tr>
		<tr>
			<td>SL 16R Centrifuge</td>
			<td>Thermo Scientific</td>
			<td>75004030</td>
		</tr>
		<tr>
			<td>Thermo Forma Series ii Water Jacketed CO2 Incubator</td>
			<td>Thermo Scientific</td>
			<td>3111</td>
		</tr>
		<tr>
			<td>Cover glass 12mm dia. thick 0.13-0.17mm</td>
			<td>Bar Naor LTD</td>
			<td></td>
		</tr>
		<tr>
			<td><a href="https://www.thermofisher.com/order/catalog/product/R0531">TurboFect Transfection Reagent</a></td>
			<td>Thermo Scientific</td>
			<td><a href="https://www.thermofisher.com/order/catalog/product/R0531">R0531</a></td>
		</tr>
		<tr>
			<td>Axiovert 100 inverted microscope</td>
			<td>Zeiss</td>
			<td></td>
		</tr>
		<tr>
			<td>IMAGING WORKBENCH 2&#160;</td>
			<td>Axon Instruments</td>
			<td></td>
		</tr>
		<tr>
			<td>Leptomycin B</td>
			<td>Sigma</td>
			<td>L2913</td>
		</tr>
		<tr>
			<td>PBS</td>
			<td>Biological Industries</td>
			<td>02-023-1A</td>
		</tr>
		<tr>
			<td>Homogenizer motor/control/chuck/90-degree clamp</td>
			<td>Glas-Col</td>
			<td>099C K5424CE</td>
		</tr>
		<tr>
			<td>MicroCL 17R Centrifuge, Refrigerated</td>
			<td>Thermo Scientific</td>
			<td>75002455</td>
		</tr>
	</tbody>
</table>

assay to measure nucleocytoplasmic transport in real time within motor neuron-like nsc-34 cells

Nucleocytoplasmic transport refers to the import and export of large molecules from the cell nucleus. Recently, a number of studies have shown a connection between amyotrophic lateral sclerosis (ALS) and impairments in the nucleocytoplasmic pathway. ALS is a neurodegenerative disease affecting the motor neurons and resulting in paralysis and ultimately in death, within 2-5 years on average. Most cases of ALS are sporadic, lacking any apparent genetic linkage, but 10% are inherited in a dominant manner. Recently, hexanucleotide repeat expansions (HREs) in the chromosome 9 open reading frame 72 (C9orf72) gene were identified as a genetic cause of ALS and frontotemporal dementia (FTD). Importantly, different groups have recently proposed that these mutants affect nucleocytoplasmic transport. These studies have mostly shown the final outcome and manifestations caused by HREs on nucleocytoplasmic transport, but they do not demonstrate nuclear transport dysfunction in real time. As a result, only severe nucleocytoplasmic transport deficiency can be determined, mostly due to high overexpression or exogenous protein insertion. 
This protocol describes a new and very sensitive assay to evaluate and quantify nucleocytoplasmic transport dysfunction in real time. The rate of import of a NLS-NES-GFP protein (shuttle-GFP) can be quantified in real time using fluorescent microscopy. This is performed by using an exportin inhibitor, thus allowing the shuttle GFP only to enter the nucleus. To validate the assay, the C9orf72 HRE translated dipeptide repeats, poly(GR) and poly(PR), which have been previously shown to disrupt nucleocytoplasmic transport, were used. Using the described assay, a 50% decrease in the nuclear import rate was observed compared to the control. Using this system, minute changes in nucleocytoplasmic transport can be examined and the ability of different factors to rescue (even partially) a nucleocytoplasmic transport defect can be determined.

Using the procedure presented here, motor neuron-like NSC-34 cells were transfected with a NLS-NES-GFP (shuttle-GFP) protein. This protein, which has NLS and NES signal sequences (Figure 1), can shuttle between the nucleus and the cytoplasm. Generic GFP can enter or exit the nucleus in the absence of any localization signal tag only by diffusion and is therefore distributed evenly between the nucleus and the cytoplasm (Figure 2A). In contrast, the shuttle...

Watch this Scientific Journal Video about Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells at JoVE.com

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

This protocol describes a method to sensitively measure the nucleocytoplasmic transport rate within motor neuron-like NSC-34 cells by quantifying the real-time change in the nuclear import of a NLS-NES-GFP protein.

Nucleocytoplasmic transport refers to the import and export of large molecules from the cell nucleus. Recently, a number of studies have shown a ...

The overall goal of this assay is to detect minute changes in the nucleocytoplasmic transport rate of cells in real time in the absence or presence of potential transport rate-suppressive molecules. This method can help answer key questions about specific neurogenetic diseases such as ALS, that have been proposed to negatively impact nucleocytoplasmic transport. Some advantages of this technique are that it is highly sensitive and quantitative and that it allows the real-time analysis of minute changes in the nucleocytoplasmic transport rate.Demonstrating the procedure will be Tom Shani, a graduate student from my laboratory. Begin by thawing approximately one times 10 to the sixth mouse neuroblastoma spinal cord cells from liquid nitrogen storage in a 37 degree Celsius water bath. When the cells are fully thawed, collect them by centrifugation, and resuspend the pellet in one milliliter of fresh medium.Then transfer the cells into 15-milliliter flask containing five milliliters of cell culture medium for an overnight incubation at 37 degrees Celsius in 5%carbon dioxide. When the cells reach 90%confluency, place eight uncoated cover slips into individual 60-millimeter culture dishes and sterilize the cover slips with 70%ethanol. Dry the cover slips under a UV light for 30 minutes.When the glass is dry, wash the cover slips with fresh medium to remove the residual ethanol. When the cover slips are ready, dissociate the neuroblastoma cells with trypsin-EDTA for about 15 seconds in the cell culture incubator. Then rest the sells for one minute at room temperature.Collect the cells by centrifugation. After counting, resuspend the pellet at a 3.5 times 10 to the fifth cells per three milliliters of medium concentration and seed three milliliters of cells per dish. Then place the cultures in the incubator for 24 hours to allow the cells to attach to the cover slips.The next day, add two micrograms of each transfection plasmid to one sterile microcentrifuge tube containing 300 microliters of DMEM medium per 60-millimeter culture dish. Add four microliters of commercial transfection reagent per two micrograms of plasmid to each tube. And vortex the DNA transfection solutions.Alternatively in cell populations where the shuttle-GFP nucleus to cytoplasmid ratio is close to a one-to-one ratio, the cells can be pre-labeled with a nuclear marker prior to their transfection to facilitate nuclear distinction. After a 25 minute incubation at room temperature, add the plasmids to each dish. And gently stir to obtain a homogenous solution.Return the cultures to the incubator for another 48 hours. Then attach the coverslips to a coverslip holder for a gentle PBS wash to remove any detached dead cells. Next place the coverslip under an inverted microscope and identify a patch of 20 to 30 GFP-expressing cells in which the nuclei are clearly defined.Use the imaging software to mark the nuclei within the patch. Then add 200 microliters of exportin-1 inhibitor leptomycin B buffer dropwise to the coverslip and quantify the fluorescence intensity of the marked nuclei in three-second intervals for around 400 to 500 seconds. After all the cover slips have been imaged, normalize the fluorescence intensity of each cell nuclei and generate a fluorescence intensity curve representing the changes in nuclear fluorescence as a function of time for each cell patch.Then analyze the maximum reaction velocity of the slope of each cell patch derived from three to five independent experiments to generate one slope per experimental group. For protein expression validation 48 hours after transfection, place the culture dishes on ice and wash the cells two times with PBS. Treat the cells in each dish with 200 to 400 microliters of lysis buffer.And use a cell scraper to remove the cells from the cover slips. Transfer the detached cells from each plate into individual microcentrifuge tubes. And further dissociate the cells with a homogenizer under ice.After one minute, pellet the homogenized cell pieces by centrifugation and measure the protein concentration in each supernatant by Bradford assay. Then pool 30 to 70 micrograms of protein per group into new microcentrifuge tubes. Store the tubes negative 20 degrees Celsius until SDS page protein expression analysis.Generic GFP can enter or exit the cell nucleus in the absence of a localization signal tag by diffusion only, resulting in an even distribution of the protein between the nucleus and the cytoplasm. In contrast, shuttle-GFP protein is mostly observed in the cytoplasm due to the nuclear export and nuclear localization signals directing its dispersion. Treatment with leptomycin B, a GFP protein export inhibitor, induces the accumulation of shuttle-GFP within the nucleus, allowing the shuttle-GFP import rate to be measured.These changes in the nuclear fluorescence intensity in the absence or presence of protein export inhibition can then be quantified in real time to assess the nuclear cytoplasmic transport rate of the shuttle-GFP overtime. To confirm that the activity of nucleolar stress-inducing dipeptide repeat proteins is not affected by protein export inhibition GFP, GFP-tagged dipeptide repeat proteins were visualized by fluorescence microscopy after leptomycin B treatment revealing poly(PR)expression in the nucleus as inclusions only, excluding the possibility of the generation of a false positive nuclear import signal. Poly(GR)expression however was observed homogenously in the cytosol and as inclusions within the nucleus.Indeed, neuroblastoma spinal cord cell transfection with poly(GR)only followed by leptmycin B treatment results in no observed shuttle movement of the expressed poly(GR)Further analysis of the nuclear cytoplasmic shuttle-GFP transport rate reveals the singular expression of either poly(PR)or poly(GR)dipeptide repeats indicating an about 50%decrease in the total nuclear import rate compared to control empty plasmid-transfected cells. We first had the idea for this method when we tried to find the quantitative assay for detecting small changes in nucleocytoplasmic dysfunction in real time. Once mastered, the microscopic analysis of the cells can be performed in approximately 10 minutes per coverslip.The data analysis for each coverslip can be completed in a few minutes. After its development, this technique paves the way for researchers in the field of neurodegenerative diseases to explore defects in nucleocytoplasmic transport using cellular models. After watching this video, you should have a good understanding of how to detect and quantify minute changes in cellular nucleocytoplasmic transport rate in real time.

assay-to-measure-nucleocytoplasmic-transport-real-time-within-motor

Research

JoVE Journal

Neuroscience

8.6K vistas.  Ben-Gurion University of the Negev. The overall goal of this assay is to detect minute changes in the nucleocytoplasmic transport rate of cells in real time in the absence or presence of potential transport rate-suppressive molecules. This method can help answer key questions about specific neurogenetic diseases such as ALS, that have been proposed to negatively impact nucleocytoplasmic transport. Some advantages of this technique are that it is highly sensitive and quantitative and that it allows the real-time analysis of minu...